7 Results for "

Functionalized Hapten

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "Functionalized Hapten" in MCE Product Catalog:

Cat. No.: HY-149738
CAS No.: 2408732-55-6
Research Areas:  

Others

FXh is a functionalized hapten activated by incubation with N, N′-disuccinimidyl carbonate, and Et3N in acetonitrile at 0 °C. FXh can improve the affinity of antigens .
loading...
    loading...
Cat. No.: HY-P10870
Research Areas:  

Cancer

Pep1-DNP conjugate 9 is a functionalized peptide which is composed of the DNP-Hapten and the FGFR1 binding peptide. Pep1-DNP conjugate 9 exhibits good affinity to FGFR1 with KD of 5.01 μM. Pep1-DNP conjugate 9 recruits anti-DNP antibodies to the surface of FGFR1-positive cells, inhibits the FGF2-induced proliferation in rat skeletal myoblast cells, and induces apoptosis. Pep1-DNP conjugate 9 exhibits antitumor efficacy in mouse models .
loading...
    loading...
Cat. No.: HY-155455
CAS No.: 2892008-07-8
Target:  

Hapten

Research Areas:  

Inflammation/Immunology

Hapten Dca is an immunizing hapten. Hapten Dca is activated by a solution of N, N′-disuccinimidyl carbonate. Hapten Dca with a carboxyl functional group is conjugated to proteins .
loading...
    loading...
Cat. No.: HY-149744
CAS No.: 2408732-52-3
Research Areas:  

Inflammation/Immunology

FXb is an immunizing and functionalized hapten and can be used for protein bioconjugates preparation .
loading...
    loading...
Cat. No.: HY-161006
Research Areas:  

Inflammation/Immunology

TETS-C4-acid (Compound 2d) is a hapten coupled directly to a carrier protein through a carboxylic acid functionality. TETS-C4-acid (Compound 2d) can be used to detect tetramethylenedisulfotetramine (TETS) .
loading...
    loading...
Cat. No.: HY-157181
CAS No.: 151749-58-5
Research Areas:  

Inflammation/Immunology

Hal-HS, a happen, fully protects and highlights the main functional groups of the molecule, thereby completely exposing it to the immune system. Hal-HS can be covalently attached to BSA via the active ester method to obtain hapten–protein conjugates (Hal-BSA) as immunogen .
loading...
    loading...
Cat. No.: HY-L076
641 compounds

Drug-induced liver injury (DILI; also known as drug-induced hepatotoxicity) is caused by medications (prescription or OTC), herbal and dietary supplements (HDS), or other xenobiotics that result in abnormalities in liver tests or in hepatic dysfunction that cannot be explained by other causes. Drugs are an important cause of liver injury. Drug-induced hepatic injury is the most common reason cited for withdrawal of an approved drug.

DILI is thought to occur via several different mechanisms. Among these are direct impairment of the structural (e.g., mitochondrial dysfunction) and functional integrity of the liver; production of a metabolite that alters hepatocellular structure and function; production of a reactive drug metabolite that binds to hepatic proteins to produce new antigenic drug-protein adducts, which are targeted by hosts’ defenses (the hapten hypothesis); and initiation of a systemic hypersensitivity response (i.e., drug allergy) that damages the liver.

MCE Drug-induced Liver Injury (DILI) Compound Library contains a unique collection of 641 hepatotoxicity causing compounds and is a powerful tool to research DILI and other drug toxicities. This library can be used to understand the mechanisms of DILI, identify biomarkers for early DILI prediction, and allow timely recognition during drug development, thus finally achieving successful DILI prevention and assessment in the pre-marketing phase.